A prospective phase I/II study to evaluate allogeneic mesenchymal stromal cells for the treatment of skin disease in children with recessive dystrophic epidermolysis bullosa

Update Il y a 4 ans
Reference: EUCTR2012-001394-87

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To evaluate the safety of allogeneic intravenously administered MSCs in children with RDEB over a 24-month period.


Inclusion criteria

  • Recessive Dystrophic Epidermolysis Bullosa

Links